A Clinical study to evaluate the efficacy of Amrutadi vati and Vasadi vati in the treatment of Bronchial Asthma(Shwasa).

A clinical study of Amrutadi vati and Vasadi vati in the management of Tamaka shwasa w.s.r. to Bronchial asthma

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/08/004927

Enrollment

Registered

2014-08-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Bronchial Asthma

Interventions

Intervention1: Amrutadi vati: orally 2tab.(500mg each) tds after food with luke warm water for 8weeks follow up 4weeks Control Intervention1: Vasadi vati: orally 2tab.(500mg each) tds after food with

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex aged between 16 to 70 years Patients having signs and symptoms of Tamak shwasa described in ayurvedic texts and modern texts will be included.

Exclusion criteria

Exclusion criteria: Patients of age less than 16 and above 70 years Patients with status asthmaticus asthma due to cardiac origin Patients having complications like cor pulmonale emphysema pneumonia tuberculosis and malignancy etc and breathlessness due to diabetes mellitus severe anaemia renal failure major endocrine disorders will be excluded from the study

Design outcomes

Primary

Measure	Time frame
Change in the clinical symptoms of Bronchial Asthma like Dyspnoea Wheezing Coughing Chest tightness etcTimepoint: 8 weeks study and 4 weeks follow up	—

Secondary

Measure	Time frame
Change in SpirometryTimepoint: 8 weeks study and 4 weeks follow up	—

Countries

India

Contacts

Public ContactDr Alankruta R Dave

Institute for Post Graduate Teaching and Research in Ayurveda

alankruta@yahoo.com9824171817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026